Nomogram for the decline in serum antimüllerian hormone: A population study of 9,601 infertility patients

Fertility and Sterility

Volumn 95, Issue 2, 2011, Pages

  Nelson, Scott M ^a   Messow, Martina C ^a   Wallace, A Michael ^b   Fleming, Richard ^a,c   McConnachie, Alex ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c Glasgow Centre for Reproductive Medicine   (United Kingdom)

Author keywords

age; AMH; infertility; normogram

Indexed keywords

MUELLERIAN INHIBITING FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FEMALE INFERTILITY; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; OLIGOSPERMIA; PRIORITY JOURNAL;

EID: 78751575456     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2010.08.022     Document Type: Article

References (29)

1. C.L. Cook, Y. Siow, S. Taylor, and M.E. Fallat Serum müllerian- inhibiting substance levels during normal menstrual cycles Fertil Steril 73 2000 859 861
2. A. La Marca, S. Malmusi, S. Giulini, L.F. Tamaro, R. Orvieto, and P. Levratti Anti-müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation Hum Reprod 19 2004 2738 2741
3. A. La Marca, G. Stabile, A.C. Artenisio, and A. Volpe Serum anti-müllerian hormone throughout the human menstrual cycle Hum Reprod 21 2006 3103 3107
4. A.G.M.G.J. Mulders, J.S.E. Laven, M.J.C. Eijkemans, F.H. de Jong, A.P.N. Themmen, and B.C.J.M. Fauser Changes in anti-müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility Hum Reprod 19 2004 2036 2042
5. I.A.J. van Rooij, F.J.M. Broekmans, G.J. Scheffer, C.W.N. Looman, J.D.F. Habbema, and F.H. de Jong Serum antimüllerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study Fertil Steril 83 2005 979 987
6. L.G. Nardo, D. Christodoulou, D. Gould, S.A. Roberts, C.T. Fitzgerald, and I. Laing Anti-Müllerian hormone levels and antral follicle count in women enrolled in in vitro fertilization cycles: relationship to lifestyle factors, chronological age and reproductive history Gynecol Endocrinol 23 2007 486 493
7. M.R. Sowers, A.D. Eyvazzadeh, D. McConnell, M. Yosef, M.L. Jannausch, and D. Zhang Anti-müllerian hormone and inhibin B in the definition of ovarian aging and the menopause transition J Clin Endocrinol Metab 93 2008 3478 3483
8. J. van Disseldorp, M.J. Faddy, A.P. Themmen, F.H. de Jong, P.H. Peeters, and Y.T. van der Schouw Relationship of serum antimüllerian hormone concentration to age at menopause J Clin Endocrinol Metab 93 2008 2129 2134
9. M.J. Faddy, R.G. Gosden, A. Gougeon, S.J. Richardson, and J.F. Nelson Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause Hum Reprod 7 1992 1342 1346
10. M.J. Faddy, and R.G. Gosden Ovary and ovulation: a model conforming the decline in follicle numbers to the age of menopause in women Hum Reprod 11 1996 1484 1486
11. M.J. Faddy Follicle dynamics during ovarian ageing Mol Cell Endocrinol 163 2000 43 48
12. K.R. Hansen, N.S. Knowlton, A.C. Thyer, J.S. Charleston, M.R. Soules, and N.A. Klein A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause Hum Reprod 23 2008 699 708
13. W.H. Wallace, and T.W. Kelsey Human ovarian reserve from conception to the menopause PLoS One 5 2010 e8772
14. R Foundation for Statistical Computing, 2009. Available at: http://www.r-project.org. Accessed August 20, 2010.
15. Tornoe CW. nlmeODE: Non-linear mixed-effects modelling in nlme using differential equations. R package version 0.3-1. Available at: http://www.cran.r-project.org. Accessed August 20, 2010.
16. Woodrow Setzer R. odesolve: Solvers for Ordinary Differential Equations. R package version 0.5-20. 2008. Available at: http://www.cran.r-project.org. Accessed August 20, 2010.
17. Pinheiro J, Bates D, DebrRoy S, Sarkar D, Team RC. NLME: linear and nonlinear mixed effects models. R package version 3.1-92. 2009.
18. J. Bezard, B. Vigier, D. Tran, P. Mauleon, and N. Josso Immunocytochemical study of anti-müllerian hormone in sheep ovarian follicles during fetal and post-natal development J Reprod Fertil 80 1987 509 516
19. W.M. Baarends, J.T. Uilenbroek, P. Kramer, J.W. Hoogerbrugge, E.C. van Leeuwen, and A.P. Themmen Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth Endocrinology 136 1995 4951 4962
20. C. Weenen, J.S.E. Laven, A.R.M. von Bergh, M. Cranfield, N.P. Groome, and J.A. Visser Anti-müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment Mol Hum Reprod 10 2004 77 83
21. P.E. Hughesdon Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called "hyperthecosis." Obstet Gynecol Surv 37 1982 59 77
22. G.A.R. Maciel, E.C. Baracat, J.A. Benda, S.M. Markham, K. Hensinger, and R.J. Chang Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome J Clin Endocrinol Metab 89 2004 5321 5327
23. R. Pasquali, and A. Gambineri Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age Ann NY Acad Sci 1092 2006 158 174
24. L. Pellatt, L. Hanna, M. Brincat, R. Galea, H. Brain, and S. Whitehead Granulosa cell production of anti-müllerian hormone is increased in polycystic ovaries J Clin Endocrinol Metab 92 2007 240 245
25. J.S. Laven, A.G. Mulders, J.A. Visser, A.P. Themmen, F.H. De Jong, and B.C. Fauser Anti-müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age J Clin Endocrinol Metab 89 2004 318 323
26. T. Piltonen, L. Morin-Papunen, R. Koivunen, A. Perheentupa, A. Ruokonen, and J.S. Tapanainen Serum anti-müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome Hum Reprod 20 2005 1820 1826
27. R. Fleming, L. Harborne, D.T. MacLaughlin, D. Ling, J. Norman, and N. Sattar Metformin reduces serum müllerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment Fertil Steril 83 2005 130 136
28. M.W. Elting, T.J.M. Korsen, L.T.M. Rekers-Mombarg, and J. Schoemaker Women with polycystic ovary syndrome gain regular menstrual cycles when ageing Hum Reprod 15 2000 24 28
29. E.J. de Boer, I. den Tonkelaar, E.R. te Velde, C.W. Burger, H. Klip, and F.E. van Leeuwen A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause Fertil Steril 77 2002 978 985